SCHEMBL7961741

SCHEMBL7961741

O=C(O)c1cccc(CC2CCCCCC=C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 13/20 0.93
PTGER4 P35408 6/20 0.93
PTGER1 P34995 1/20 0.93
PTGER3 P43115 2/20 0.66
PPM1D O15297 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FABP4 P15090 2/20 0.38
TBXA2R P21731 1/20 0.37
PTGER2 P43116 1/20 0.37
PTGDR Q13258 1/20 0.37
NR4A2 P43354 1/20 0.37
FABP3 P05413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961736 1.00 PTGIR (0.93) PTGIRPTGER4PTGER1PTGER3PPM1D
SCHEMBL7960399 0.99 PTGIR (0.94) PTGIRPTGER4PTGER1PTGER3PPM1D
SCHEMBL1626140 0.96 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7960055 0.96 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL4576000 0.96 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7958123 0.93 PTGIR (0.89) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7949886 0.93 PTGIR (0.89) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7952704 0.92 PTGIR (0.82) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7960001 0.90 PTGIR (0.78) PTGIRPTGER4PTGER1PTGER3PPM1D
SCHEMBL7959445 0.89 PTGIR (0.86) PTGIRPTGER4PTGER1PTGER3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed